bevacizumab,trifluridine tipiracil
taiho pharma,roche,otsuka
[]
at #gi23, released data from sunlight, a phase 3 global trial that showed a 3-month increase in survival rate using the combination of trifluridine/tipiracil &amp; bevacizumab in adults w/ refractory metastatic colorectal cancer. learn more: 
The Colorectal Cancer Alliance is a national nonprofit fiercely dedicated to ending colorectal cancer within our lifetime. #TomorrowCantWait